Literature DB >> 23929434

The highly prevalent BRCA2 mutation c.2808_2811del (3036delACAA) is located in a mutational hotspot and has multiple origins.

Mar Infante1, Mercedes Durán, Alberto Acedo, Eva María Sánchez-Tapia, Beatriz Díez-Gómez, Alicia Barroso, María García-González, Lídia Feliubadaló, Adriana Lasa, Miguel de la Hoya, Eva Esteban-Cardeñosa, Orland Díez, Cristina Martínez-Bouzas, Javier Godino, Alexandre Teulé, Ana Osorio, Enrique Lastra, Rogelio González-Sarmiento, Cristina Miner, Eladio A Velasco.   

Abstract

BRCA2-c.2808_2811del (3036delACAA) is one of the most reported germ line mutations in non-Ashkenazi breast cancer patients. We investigated its genetic origin in 51 Spanish carrier families that were genotyped with 11 13q polymorphic markers. Three independent associated haplotypes were clearly distinguished accounting for 23 [west Castilla y León (WCL)], 20 [east Castilla y León (ECL)] and 6 (South of Spain) families. Mutation age was estimated with the Disequilibrium Mapping using Likelihood Estimation software in a range of 45-68 and 45-71 generations for WCL and ECL haplotypes, respectively. The most prevalent variants, c.2808_2811del and c.2803G > A, were located in a double-hairpin loop structure (c.2794-c.2825) predicted by Quikfold that was proposed as a mutational hotspot. To check this hypothesis, random mutagenesis was performed over a 923 bp fragment of BRCA2, and 86 DNA variants were characterized. Interestingly, three mutations reported in the mutation databases (c.2680G > A, c.2944del and c.2957dup) were replicated and 20 affected the same position with different nucleotide changes. Moreover, five variants were placed in the same hairpin loop of c.2808_2811del, and one affected the same position (c.2808A > G). In conclusion, our results support that at least three different mutational events occurred to generate c.2808_2811del. Other highly prevalent DNA variants, such as BRCA1-c.68_69delAG, BRCA2-c.5946delT and c.8537delAG, are concentrated in hairpin loops, suggesting that these structures may represent mutational hotspots.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23929434     DOI: 10.1093/carcin/bgt272

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  4 in total

1.  Durable clinical benefit from PARP inhibition in a platinum-sensitive, BRCA2-mutated pancreatic cancer patient after earlier progression on placebo treatment on the POLO trial: a case report.

Authors:  Douglas Rubinson; Brian M Wolpin; Ilana S Warsofsky; David P Ryan; Kimberly Perez; Osama Rahma; Harshabad Singh; Matthew B Yurgelun; Geoffrey I Shapiro; Andrew J Aguirre; Alan D D'Andrea; James M Cleary
Journal:  J Gastrointest Oncol       Date:  2021-12

2.  Case Report: Male Lobular Breast Cancer in Hereditary Cancer Syndromes.

Authors:  Ileana Carnevali; Gianluca Tedaldi; Valeria Pensotti; Nora Sahnane; Donata Micello; Francesca Rovera; Fausto Sessa; Maria Grazia Tibiletti
Journal:  Front Oncol       Date:  2022-05-24       Impact factor: 5.738

3.  Mutational analysis of BRCA1/2 in a group of 134 consecutive ovarian cancer patients. Novel and recurrent BRCA1/2 alterations detected by next generation sequencing.

Authors:  Magdalena Ratajska; Magdalena Krygier; Maciej Stukan; Alina Kuźniacka; Magdalena Koczkowska; Mirosław Dudziak; Marcin Śniadecki; Jarosław Dębniak; Dariusz Wydra; Izabela Brozek; Wojciech Biernat; Ake Borg; Janusz Limon; Bartosz Wasąg
Journal:  J Appl Genet       Date:  2014-11-01       Impact factor: 3.240

4.  Identification of Eight Spliceogenic Variants in BRCA2 Exon 16 by Minigene Assays.

Authors:  Eugenia Fraile-Bethencourt; Alberto Valenzuela-Palomo; Beatriz Díez-Gómez; Alberto Acedo; Eladio A Velasco
Journal:  Front Genet       Date:  2018-05-24       Impact factor: 4.599

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.